To assess the efficacy and safety of non-vitamin K antagonist oral anticoagulant rivaroxaban in patients with non-valvular atrial fibrillation
By: Lijun Qin, Yanhong Mou and Yan Guo
DOI: https://doi.org/10.2478/ahem-2025-0018 | Journal eISSN: 1732-2693
Language: English
Page range: 145 - 158
Submitted on: Feb 27, 2025
Accepted on: Jul 22, 2025
Published on: Oct 21, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2025 Lijun Qin, Yanhong Mou, Yan Guo, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.